Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
04/2006
04/18/2006US7029918 For reference standards in immunoassays; drug screening
04/13/2006US20060079512 10-farnesyl-4,6,8-tri(bisbenzyloxyphosphoryloxy)-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one; antitumor, anticarcinogenic agent; solid (pancreatic, prostate, colorectal, lung, ovarian cancer) or hematopoietic (leukemia or lymphoma) neoplasm; bactericide, inhibitor of 5-lipoxygenase, cyclooxygenase-2
04/13/2006US20060079509 Antineoplastic agents; inhibitors of cancer cell growth, mammalian lipoxygenase, acute and chronic inflammation
04/13/2006US20060079508 10-farnesyl-4,6,8-trihydroxy-dibenzodiazepin-11-one; ECO-4601; anticarcinogenic, antitumor agent; early stage of cancer; reducing side-effects on normal cells
04/13/2006US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
04/06/2006WO2006034567A1 Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
04/06/2006WO2006001866A3 Crystalline forms of n-desmethylclozapine
04/06/2006CA2581658A1 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
04/05/2006EP1294720B1 Non-nucleoside reverse transcriptase inhibitors
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
04/04/2006CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
03/2006
03/30/2006US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/30/2006US20060069083 Pesticidal dibenzo(hetero)azepine derivatives
03/29/2006EP1640368A2 Cyclic ureas and processes for their preparation
03/29/2006EP1064300A4 Peptide turn mimetics
03/28/2006US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer
03/28/2006US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
03/23/2006WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
03/23/2006DE19547099B4 Verfahren zur Herstellung von (Meth)acrylsäureestern Acrylic acid esters, process for the preparation of (meth)
03/22/2006EP1636197A1 Novel 3-substituted-1,4-benzodiazepines
03/21/2006US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine
03/21/2006US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
03/21/2006CA2186285C Carbonyl containing compounds and their derivatives as multi-functional fuel and lube additives
03/16/2006WO2006028161A1 Serotonin 5-ht3 receptor agonist
03/15/2006EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups
03/15/2006CN1747938A Novel substituted 2,3-benzodiazepine derivatives
03/09/2006WO2005091697A3 Thiourea compositions and uses thereof
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands
03/09/2006US20060052396 Arylamines for the treatment of conditions associated with gsk-3
03/08/2006CN1745083A Pyrrolo[2,1-c][1,4] benzodiazepines as vasopressin agonists
03/08/2006CN1745076A Malonamide derivatives as gamma-secretase inhibitors
03/07/2006US7008945 Amide derivatives
03/07/2006US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
03/02/2006WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase
03/02/2006CA2578370A1 Triazolobenzodiazepines and their use as vasopressin antagonists
03/01/2006CN1740173A Inhibitors of interleukin-1beta converting enzyme
03/01/2006CN1243724C Amide derivatives which are useful as cell factor inhibitors
02/2006
02/23/2006US20060040923 1,1-Diethyl-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea; respiratory syncytial virus; cost efficient replacement for Synagis (palivizumab) used for RSV; respiratory system disorders; asthna; viral diseases; myxoviruses; mumps; flaviviruses; dengue, West Nile, parainfluenza viruses
02/23/2006US20060040921 Process and intermediates for the preparation of olanzapine
02/23/2006CA2577060A1 Substituted benzofused heterocycles
02/23/2006CA2575979A1 Novel serotonin receptor ligands and their uses thereof
02/23/2006CA2573730A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders
02/22/2006CN1738820A Novel diazabicyclic aryl derivatives
02/22/2006CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache
02/22/2006CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups
02/16/2006US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase
02/16/2006US20060034773 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
02/15/2006CN1735609A Diazepanes derivatives useful as LFA inhibitors
02/09/2006WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds
02/09/2006US20060030553 Cell adhesion inhibitors
02/08/2006EP1622865A2 Novel bioisosteres of actinonin
02/08/2006EP1183243B1 Short-acting benzodiazepines
02/07/2006US6995269 Guanidinobenzamides
02/07/2006US6995155 Imines such as 4-(3-((3-(2,4-dichlorophenyl)propanoyl)amino)-1-(3-(morpholin-4-yl)propyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)benzamide, administered for prophylaxis of Alzheimer's disease
02/07/2006CA2360308C Glucocorticoid receptor modulators
02/02/2006WO2006010511A1 Method for producing 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1h)-on
02/02/2006US20060025407 Succinoylaminobenzodiazepines as inhibitors of Abeta protein production
02/02/2006US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
02/02/2006US20060024832 Water-soluble derivatives of lipophilic drugs
02/01/2006EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds
02/01/2006CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/01/2006CN1239158C 2-methyl-thieno-benzodiazepine formulation
01/2006
01/26/2006US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections
01/26/2006CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
01/25/2006EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives
01/25/2006EP1619187A1 Process for the preparation of 3-(4-piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-on
01/25/2006EP1618096A1 11-phenyl-dibenzodiazepine derivatives as rxr-antagonists
01/25/2006EP1617807A2 Substituted 1,4-diazepines and uses thereof
01/25/2006CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
01/18/2006EP1616867A1 Hydroxycarboxylic acid derivatives
01/18/2006EP1616859A1 Substituted cyclohexyl carboxylic acid compounds
01/18/2006EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
01/18/2006EP1220852B1 Substituted diazepans
01/12/2006WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
01/12/2006US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases
01/12/2006US20060009446 New compounds
01/12/2006CA2572874A1 Urea derivative
01/12/2006CA2570185A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
01/11/2006EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them
01/10/2006US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists
01/10/2006US6984626 For therapy and prophylaxis of Alzheimer's disease
01/10/2006CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders
01/10/2006CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists
01/05/2006WO2006001866A2 Crystalline forms of n-desmethylclozapine
01/05/2006CA2560671A1 Crystalline forms of n-desmethylclozapine
01/04/2006EP1611110A1 Adenosine deaminase inhibitor and novel bacillus sp. iada-7 strain which produces it
12/2005
12/29/2005US20050288275 New compounds
12/28/2005EP1608650A1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents
12/28/2005EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/28/2005EP0945445B9 1,5-benzodiazepine derivatives
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/22/2005US20050282800 Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/08/2005WO2005116034A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005WO2004096134A3 Substituted 1,4-diazepines and uses thereof
12/08/2005CA2568056A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/07/2005EP0957917B1 Vitronectin receptor antagonists
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 60